Dashboard
Manage Tickers

LFVN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

correction-on-september-4-2025-lifevantage-reported-that-it-sees-fy2026-adj-eps-100-115-vs-100-est-sees-sales-225000m-240000m-vs-252400m-est
CORRECTION: On September 4, 2025 Lifevanta...
09/06/2025 16:03:59

Lifevantage (NASDAQ:LFVN) is looking for FY2026 Adj EPS of $1.00-$1.15 vs $1.00 analyst estimate. sees sales of $225.000 millio...

american-outdoor-brands-posts-downbeat-results-joins-lululemon-quanex-building-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
American Outdoor Brands Posts Downbeat Res...
09/05/2025 12:48:05

why-docusign-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Docusign Shares Are Trading Higher By ...
09/05/2025 09:20:59

lifevantage-q4-adj-eps-017-beats-015-estimate-sales-55114m-miss-56900m-estimate
Lifevantage Q4 Adj. EPS $0.17 Beats $0.15 ...
09/04/2025 20:05:51

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.15 by ...

Core News & Articles
Earnings Scheduled For September 4, 2025
09/04/2025 08:32:12

lifevantage-acquires-lovebiome-terms-not-disclosed
LifeVantage Acquires LoveBiome; Terms Not ...
09/03/2025 21:14:41

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company ...

whats-next-lifevantages-earnings-preview
What's Next: Lifevantage's Earnings Preview
09/03/2025 16:01:56

lifevantage-expands-human-clinical-study-for-mindbody-glp-1-system
LifeVantage Expands Human Clinical Study F...
07/22/2025 12:09:47

lifevantage-raises-fy2025-adj-eps-guidance-from-070-080-to-072-088-vs-078-est-lowers-fy2025-sales-guidance-from-23500m-24500m-to-22800m-23500m-vs-23974m-est
Lifevantage Raises FY2025 Adj EPS Guidance...
05/06/2025 20:15:01

Lifevantage (NASDAQ:LFVN) raises FY2025 Adj EPS guidance from $0.70-$0.80 to $0.72-$0.88 vs $0.78 analyst estimate. Lowers FY20...

lifevantage-q3-eps-026-beats-014-estimate-sales-5840m-miss-6096m-estimate
Lifevantage Q3 EPS $0.26 Beats $0.14 Estim...
05/06/2025 20:11:56

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.14 by ...

lifevantage-board-raises-quarterly-cash-dividend-by-125-to-from-004-to-0045-per-share
LifeVantage Board Raises Quarterly Cash Di...
05/06/2025 20:10:38

LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health ...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

why-reshape-lifesciences-shares-are-trading-higher-by-over-82-here-are-20-stocks-moving-premarket
Why ReShape Lifesciences Shares Are Tradin...
04/10/2025 09:26:21

Core News & Articles
FDA Says Novo Nordisk's Ozempic Injection ...
02/21/2025 14:22:44

earnings-breakdown-lifevantage-q2
Earnings Breakdown: Lifevantage Q2
02/05/2025 21:55:56

lifevantage-q2-earnings-insights
Lifevantage: Q2 Earnings Insights
02/05/2025 21:51:59

lifevantage-q2-earnings-assessment
Lifevantage Q2 Earnings Assessment
02/05/2025 21:45:47

lifevantage-earnings-report-q2-overview
Lifevantage Earnings Report: Q2 Overview
02/05/2025 21:40:40

lifevantage-affirms-fy2025-sales-guidance-from-23500m-24500m-to-23500m-24500m-vs-23848m-est
Lifevantage Affirms FY2025 Sales Guidance ...
02/05/2025 21:38:15

Lifevantage (NASDAQ:LFVN) affirms FY2025 sales outlook from $235.00 million-245.00 million to $235.00 million-245.00 million vs...

lifevantage-q2-adj-022-beats-013-estimate-sales-6776m-beat-6739m-estimate
Lifevantage Q2 Adj $0.22 Beats $0.13 Estim...
02/05/2025 21:37:29

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.13 by ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION